Artelo Biosciences, Inc. (ARTL) Tops Q2 EPS by 4c

Artelo Biosciences, Inc. (NASDAQ: ARTL) reported Q2 EPS of ($0.75), $0.04 better than the analyst estimate of ($0.79).

For earnings history and earnings-related data on Artelo Biosciences, Inc. (ARTL) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Morgan Stanley Downgrades Repsol SA (REP:SM) (REPYY) to Equalweight
• Trifecta Gold closes $1.66M private placement for Yukon exploration